Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors
David M Roy,1 Logan A Walsh21Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program, New York, NY, USA; 2Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USAAbstract: The extracellular matrix (ECM) is the complex network of proteins...
Guardado en:
Autores principales: | Roy DM, Walsh LA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a2dce6037074d9e9b7cd232e3f81e4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Mathieu F. Bakhoum, et al.
Publicado: (2021) -
Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment
por: Naixue Yang, et al.
Publicado: (2021) -
Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
por: Zienolddiny S, et al.
Publicado: (2011) -
PI3K mutations in breast cancer: prognostic and therapeutic implications
por: Mukohara T
Publicado: (2015) -
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
por: Stephen Johnston, et al.
Publicado: (2021)